Cargando…
MTAP loss: a possible therapeutic approach for glioblastoma
Glioblastoma is the most lethal form of brain tumor with a recurrence rate of almost 90% and a survival time of only 15 months post-diagnosis. It is a highly heterogeneous, aggressive, and extensively studied tumor. Multiple studies have proposed therapeutic approaches to mitigate or improve the sur...
Autores principales: | Patro, C. Pawan K., Biswas, Nupur, Pingle, Sandeep C., Lin, Feng, Anekoji, Misa, Jones, Lawrence D., Kesari, Santosh, Wang, Feng, Ashili, Shashaanka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791736/ https://www.ncbi.nlm.nih.gov/pubmed/36572880 http://dx.doi.org/10.1186/s12967-022-03823-8 |
Ejemplares similares
-
Exploring the role of cerebrospinal fluid as analyte in neurologic disorders
por: Pingle, Sandeep C, et al.
Publicado: (2023) -
Anomaly Detection Framework for Wearables Data: A Perspective Review on Data Concepts, Data Analysis Algorithms and Prospects
por: Sunny, Jithin S., et al.
Publicado: (2022) -
Traumatic brain injury and immunological outcomes: the double-edged killer
por: Datta, Souvik, et al.
Publicado: (2023) -
Mesenchymal stem cells as living anti-inflammatory therapy for COVID-19 related acute respiratory distress syndrome
por: Lin, Feng, et al.
Publicado: (2020) -
Smart Consumer Wearables as Digital Diagnostic Tools: A Review
por: Chakrabarti, Shweta, et al.
Publicado: (2022)